SCHEMBL20152232

SCHEMBL20152232

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-n4c5ccccc5c5c6c7ccccc7n(-c7nc(-c8ccccc8)cc(-c8ccccc8)n7)c6ccc54)cc3)n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.43
KMT2A Q03164 9/20 0.43
MEN1 O00255 8/20 0.43
HPGD P15428 8/20 0.43
ALDH1A1 P00352 7/20 0.43
NTSR1 P30989 1/20 0.43
KDM4E B2RXH2 7/20 0.39
L3MBTL1 Q9Y468 4/20 0.39
ATM Q13315 1/20 0.39
LMNA P02545 2/20 0.39
GLA P06280 1/20 0.39
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
NPSR1 Q6W5P4 4/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPK1 P28482 4/20 0.36
MAOA P21397 1/20 0.36
MAOB P27338 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152167 0.99 MAPT (0.46) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL26059907 0.97 KMT2A (0.47) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL20152205 0.97 KMT2A (0.47) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL26057989 0.96 KMT2A (0.46) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL26057407 0.96 KMT2A (0.46) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL26059912 0.96 KMT2A (0.46) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL26057385 0.96 KMT2A (0.46) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL23598396 0.95 KMT2A (0.47) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL23598393 0.95 KMT2A (0.47) MAPTKMT2AMEN1HPGDALDH1A1
SCHEMBL23370573 0.95 L3MBTL1 (0.41) MAPTKMT2AMEN1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662196-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-05-26 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662196-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, SLCO4C1 MAPT 689/4885KMT2A 3996/4885MEN1 4244/4885
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, SLCO4C1 MAPT 689/4885KMT2A 3996/4885MEN1 4244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.